Tumor Suppression by the Fbw7 Ubiquitin Ligase: Mechanisms and Opportunities

Cited by (347)

Items 201–300 of 347

  1. The Biology of SUMO-Targeted Ubiquitin Ligases in Drosophila Development, Immunity, and Cancer
    Mona Abed, Eliya Bitman-Lotan, Amir Orian · 2018 · Journal of Developmental Biology
  2. N6-Isopentenyladenosine Inhibits Colorectal Cancer and Improves Sensitivity to 5-Fluorouracil Targeting FBXW7 Tumor Suppressor
    Donatella Fiore, Chiara Piscopo, Maria Proto, Michele Vasaturo, Fabrizio Dal Piaz, Bruno Fusco, Cristina Pagano, Chiara Laezza, Maurizio Bifulco, Patrizia Gazzerro · 2019 · Cancers
  3. Co-regulation of the antagonistic RepoMan:Aurora-B pair in proliferating cells
    Maria Giulia Manzione, Jan Rombouts, Mikhail Yu. Steklov, Lorenzo Pasquali, Anna A. Sablina, Lendert Gelens, Junbin Qian, Mathieu Bollen · 2020 · Molecular Biology of the Cell
  4. Ubiquitin, the centrosome, and chromosome segregation
    Ying Zhang, Paul J. Galardy · 2015 · Chromosome Research
  5. Hepatocyte FBXW7-dependent activity of nutrient-sensing nuclear receptors controls systemic energy homeostasis and NASH progression in male mice
    Hui Xia, Catherine R. Dufour, Younes Medkour, Charlotte Scholtes, Yonghong Chen, Christina Guluzian, Wafa B'Chir, Vincent Giguère · 2023 · Nature Communications
  6. FBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies
    Wanqing Wang, Kaipeng Jiang, Xue Liu, Ju Li, Wenshuo Zhou, Chang Wang, Jiuwei Cui, Tingting Liang · 2023 · Frontiers in Pharmacology
  7. The dimeric deubiquitinase USP28 integrates 53BP1 and MYC functions to limit DNA damage
    Chao Jin, Elias Einig, Wenshan Xu, Ravi Babu Kollampally, Andreas Schlösser, M. Flentje, Nikita Popov · 2024 · Nucleic Acids Research
  8. Stabilization of nuclear oncoproteins by RNF4 and the ubiquitin system in cancer
    Markus E. Diefenbacher, Amir Orian · 2016 · Molecular & Cellular Oncology
  9. CK1δ/GSK3β/FBXW7α axis promotes degradation of the ZNF322A oncoprotein to suppress lung cancer progression
    S-Y Liao, C-W Chiang, Chun‐Hua Hsu, Y-T Chen, Jayu Jen, Hsueh‐Fen Juan, W-W Lai, Y-C Wang · 2017 · Oncogene
  10. A negative feedback loop between XBP1 and Fbw7 regulates cancer development
    Unbin Chae, Heejin Lee, Bokyung Kim, Haiyoung Jung, Byeong Mo Kim, Ann- Hwee Lee, Dong‐Seok Lee, Sang‐Hyun Min · 2019 · Oncogenesis
  11. Targeting Msx2 as a brake in the fusion fate of osteoclasts and an anabolic therapy in pre-clinical models of osteoporosis
    Ma, Qingliang, Wang, Shiyu, Xue, Hong, Ni, Linhui, Yuan, Putao, Shen, Yang, Zheng, Bingjie, Wang, Qingqing, Zhang, Jiateng, Wang, Haoming et al. · 2025 · Nature Communications
  12. The PP2A-B56 phosphatase opposes cyclin E autocatalytic degradation via site-specific dephosphorylation
    Davis, Ryan J., Swanger, Jherek, Hughes, Bridget T., Clurman, Bruce E. · 2017 · Molecular and Cellular Biology
  13. High‐risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels
    Mary Ellen Urick, Eun‐Jeong Yu, Daphne W. Bell · 2021 · Cancer
  14. Early growth response-1 is a new substrate of the GSK3β-FBXW7 axis
    Lu Yin, Jiagui Zhang, Yi Sun · 2022 · Neoplasia
  15. The SCF–FBXW7 E3 ubiquitin ligase triggers degradation of histone 3 lysine 4 methyltransferase complex component WDR5 to prevent mitotic slippage
    Simon Hänle-Kreidler, Kai T. Richter, Ingrid Hoffmann · 2022 · Journal of Biological Chemistry
  16. Role of CELF2 in ferroptosis: Potential targets for cancer therapy (Review)
    Jiahao Li, Lei Xian, Zifeng Zhu, Yang Wang, Wenlei Zhang, Ruipeng Zheng, Xue Wang, Jiarui Li · 2023 · International Journal of Molecular Medicine
  17. Active AKT2 stimulation of SREBP1/SCD1-mediated lipid metabolism boosts hepatosteatosis and cancer
    Fuqiang Huang, Na Zhao, Pei Cai, Mengjie Hou, Shuhui Yang, Bohao Zheng, Qian Ma, Jingpeng Jiang, Xiaochen Gai, Yilei Mao et al. · 2024 · Translational research
  18. Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer
    Nathan F. Schachter, Jessica R. Adams, Patryk Skowron, Katelyn J. Kozma, Christian A. Lee, Nandini Raghuram, Joanna Yang, Amanda J. Loch, Wei Wang, Aaron Kucharczuk et al. · 2021 · Nature Communications
  19. E3 ligase FBXW7 aggravates TMPD-induced systemic lupus erythematosus by promoting cell apoptosis
    Zhenlu Chong, Chunjing Bao, Jia He, Tianxiao Chen, Lijia Zhong, Gaopeng Li, Huanle Li, Lutong Fang, Yinjing Song, Guoxiang Fu et al. · 2018 · Cellular and Molecular Immunology
  20. E3 ubiquitin ligase FBXW7 enhances radiosensitivity of non-small cell lung cancer cells by inhibiting SOX9 regulation of CDKN1A through ubiquitination
    Hongge Zhu, Xiuli Wang, Xin Zhou, Suqiong Lu, Guomin Gu, Chunling Liu · 2022 · Laboratory Investigation
  21. FBW7 suppresses cell proliferation and G2/M cell cycle transition via promoting γ-catenin K63-linked ubiquitylation
    Yu Li, Kaishun Hu, Xing Xiao, Wenjing Wu, Haiyan Yan, Hengxing Chen, Zhen Chen, Dong Yin · 2018 · Biochemical and Biophysical Research Communications
  22. FBW7 in hematological tumors (Review)
    Qiaojuan Zhu, Linjun Hu, Yang Guo, Zunqiang Xiao, Qiuran Xu, Xiangmin Tong · 2020 · Oncology Letters
  23. Function and regulation of F‑box/WD repeat‑containing protein 7 (Review)
    Zheng Zhang, Qiangsheng Hu, Wenyan Xu, Wensheng Liu, Mengqi Liu, Qiqing Sun, Ye Zeng, Guixiong Fan, Yi Qin, Xiaowu Xu et al. · 2020 · Oncology Letters
  24. Fbxw7 suppresses cancer metastasis by inhibiting niche formation
    Kanae Yumimoto, Keiichi I. Nakayama · 2015 · OncoImmunology
  25. Ubiquitin Ligase, Fbw7, Targets CDX2 for Degradation via Two Phosphodegron Motifs in a GSK3β-Dependent Manner
    Yogesh Kumar, Nidhi Shukla, Gatha Thacker, Isha Kapoor, Savita Lochab, Madan Lal Brahma Bhatt, Naibedya Chattopadhyay, Sabyasachi Sanyal, Arun Kumar Trivedi · 2016 · Molecular Cancer Research
  26. Recurrent mutations in tumor suppressor FBXW7 bypass Wnt/β-catenin addiction in cancer
    Zheng Zhong, David M. Virshup · 2024 · Science Advances
  27. GPX4 methylation puts a brake on ferroptosis
    Graeme Iain Lancaster, Andrew James Murphy · 2025 · Nature Cell Biology
  28. The role of FBXW7, a cell-cycle regulator, as a predictive marker of recurrence of gastrointestinal stromal tumors
    Yuki Koga, Masaaki Iwatsuki, Kohei Yamashita, Yuki Kiyozumi, Junji Kurashige, Toshiro Masuda, Kojiro Eto, Shiro Iwagami, Kazuto Harada, Takatsugu Ishimoto et al. · 2019 · Gastric Cancer
  29. SIK2 : A critical glucolipid metabolic reprogramming regulator and potential target in ovarian cancer
    Dan Hu, Junhong Du, Yijuan Xing, YueMei Cheng, Ruifen He, Xiaolei Liang, Hongli Li, Yongxiu Yang · 2023 · Journal of obstetrics and gynaecology research
  30. Role of the ubiquitin–proteasome system on macrophages in the tumor microenvironment
    Yue Xiao, Ruiqian Liu, Na Li, Yong Li, Xuan Huang · 2024 · Journal of Cellular Physiology
  31. Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma
    Irene Vázquez-Domínguez, Laura González-Sánchez, Pilar López‐Nieva, Pablo Fernández‐Navarro, María Villa‐Morales, María Cobos-Fernández, Isabel Sastre, Mario F. Fraga, Agustín F. Fernández, Marcos Malumbres et al. · 2019 · Oncogene
  32. RNAi screen reveals synthetic lethality between cyclin G-associated kinase and FBXW7 by inducing aberrant mitoses
    Saoirse Olivia Dolly, Mark D. J. Gurden, Konstantinos G. Drosopoulos, Paul Andrew Clarke, Johann Sebastian De Bono, Stan B. Kaye, Paul Workman, Spiros Linardopoulos · 2017 · British Journal of Cancer
  33. Correlation between high FBXW7 expression in pretreatment biopsy specimens and good response to chemoradiation therapy in patients with locally advanced esophageal cancer: A retrospective study
    Navchaa Gombodorj, Takehiko Yokobori, Naritaka Tanaka, Shigemasa Suzuki, Kengo Kuriyama, Yuji Kumakura, Tomonori Yoshida, Makoto Sakai, Makoto Sohda, Seded Baatar et al. · 2018 · Journal of Surgical Oncology
  34. Molecular genetics of meningiomas
    Mark W. Youngblood, Murat Günel · 2020 · Handbook of clinical neurology
  35. Revealing the contribution of somatic gene mutations to shaping tumor immune microenvironment
    Liwen Xu, Shiwei Zhu, Yujia Lan, Min Yan, Zedong Jiang, Jiali Zhu, Gaoming Liao, Yanyan Ping, Jinyuan Xu, Bo Pang et al. · 2022 · Briefings in Bioinformatics
  36. Erythropoietin regulates energy metabolism through EPO-EpoR-RUNX1 axis
    Weiqin Yin, Praveen Kumar Rajvanshi, Heather Marie Rogers, Teruhiko Yoshida, Jeffrey B. Kopp, Xiuli An, Max Gassmann, Constance Tom Noguchi · 2024 · Nature Communications
  37. Targeting PD-1 post-translational modifications for improving cancer immunotherapy
    Jie Shi, Chuan He, Li Chen, Xixin Xing, Wenyi Wei, Jinfang Zhang · 2025 · Cell Insight
  38. Characterization of the F-box Proteins FBXW2 and FBXL14 in the Initiation of Bone Regeneration in Transplants given to Nude Mice
    Mari Akiyama · 2018 · The Open Biomedical Engineering Journal
  39. NEDD4L suppresses PD-L1 expression and enhances anti-tumor immune response in A549 cells
    Bin Zhong, Jie Zheng, Huilan Wen, Xinhui Liao, Xingxiang Chen, Yunwei Rao, Ping Yuan · 2022 · Genes & Genomics
  40. Global and context-specific transcriptional consequences of oncogenic Fbw7 mutations
    H. Nayanga Thirimanne, Feinan Wu, Derek H. Janssens, Jherek Swanger, Ahmed Diab, Heather M Feldman, Robert A. Amezquita, Raphaël Gottardo, Patrick J Paddison, Steven Henikoff et al. · 2022 · eLife
  41. An innate pathogen sensing strategy involving ubiquitination of bacterial surface proteins
    Shruti Apte, Smita Bhutda, Sourav Ghosh, Kuldeep Sharma, Thomas E. Barton, Soham Dibyachintan, Osheen Sahay, Suvapriya Roy, Akash Raj Sinha, Harikrishna Adicherla et al. · 2023 · Science Advances
  42. MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastoma
    Grafals-Ruiz, Nilmary, Sánchez-Álvarez, Annelis O., Santana-Rivera, Yasmarie, Lozada-Delgado, Eunice L., Rabelo-Fernandez, Robert J., Rios-Vicil, Christian I., Valiyeva, Fatima, Vivas-Mejia, Pablo E. · 2023 · Frontiers in Oncology
  43. Poor prognosis in cholangiocarcinoma patients with low FBXW7 expression is improved by chemotherapy
    Norihiro Ishii, Kenichiro Araki, Takehiko Yokobori, Akira Watanabe, Mariko Tsukagoshi, Norio Kubo, Hideki Suzuki, Fumiyoshi Saito, Bolag Altan, Yasuo Hosouchi et al. · 2017 · Oncology Letters
  44. The ubiquitin-proteasome pathway in adult and pediatric brain tumors: biological insights and therapeutic opportunities
    Wafik Tharwat Zaky, Christa A. Manton, Claudia P. Miller, Soumen Khatua, Vidya Gopalakrishnan, Joya Chandra · 2017 · Cancer and Metastasis Reviews
  45. Retracted Article: Iso-pencillixanthone A from a marine-derived fungus reverses multidrug resistance in cervical cancer cells through down-regulating P-gp and re-activating apoptosis
    Li Chen, Xinxin Li, Miaomiao Cheng, Siyuan Wang, Qiuhong Zheng, Qinying Liu · 2018 · RSC Advances · Retracted
  46. Critical roles of the E3 ubiquitin ligase FBW7 in B‐cell response and the pathogenesis of experimental autoimmune arthritis
    Chunlei Feng, Lingyun Li, Lei Zhou, Dali Li, Mingyao Liu, Shuhua Han, Biao Q Zheng · 2021 · Immunology
  47. E3 Ubiquitin Ligases: Structures, Biological Functions, Diseases, and Therapy
    Haochen Wang, Junbo Peng, Hongchan Li, Yuzhe Lan, Jing Guo, Qiang Qiu, Xuan Huang · 2025 · MedComm
  48. The FBXW7–KMT2 axis in cancer-associated fibroblasts controls tumor growth via an epigenetic-paracrine mechanism
    Lu Yin, Jiagui Zhang, Zhipeng Zhu, Xiaojuan Peng, Huiyin Lan, Alex M. Ayoub, Mingjia Tan, Bo O. Zhou, Yaohui He, Siyuan Wang et al. · 2025 · Proceedings of the National Academy of Sciences
  49. Protein Ubiquitination Modification in Pulmonary Fibrosis
    Jinping Shen, Yuling Jiang, Wenxia Bu, Mengjiao Yu, Ruiyao Huang, Can Tang, Zeyun Yang, Haiping Gao, Liling Su, Demin Cheng et al. · 2025 · Comprehensive physiology
  50. The DCDC2/ENO1 axis promotes tumor progression and immune evasion in intrahepatic cholangiocarcinoma via activating FGL1-LAG3 checkpoint
    Wenze Wan, Yuan Li, Wentao Sun, Zewei Cheng, Fen Ma, Sheng Shen, Houbao Liu, Jiwei Zhang · 2025 · Journal of Experimental & Clinical Cancer Research
  51. Verrucous carcinoma of the oesophagus is a genetically distinct subtype of oesophageal squamous cell carcinoma
    Raymond A. Isidro, Fei Dong, Jason L. Hornick, Jon O. Wee, Agoston Agoston, Deepa T. Patil, Vikram Deshpande, Lei Zhao · 2021 · Histopathology
  52. FAM83D promotes the proliferation and migration of hepatocellular carcinoma cells by inhibiting the FBXW7/MCL1 pathway
    Jiao Nie, Lin Lü, Chao Du, Xiaozhong Gao · 2022 · Translational Cancer Research
  53. Establishment and analysis of a novel mouse line carrying a conditional knockin allele of a cancer-specific FBXW7 mutation
    Tsuneo Ikenoue, Yumi Terakado, Chi Zhu, Xun Liu, Tomoyuki Ohsugi, Daisuke Matsubara, Tomoki Fujii, Shigeru Kakuta, Sachiko Kubo, Takuma Shibata et al. · 2018 · Scientific Reports
  54. The ubiquitin ligase FBXW7 targets the centriolar assembly protein HsSAS-6 for degradation and thereby regulates centriole duplication
    Binshad Badarudeen, Ria Gupta, Sreeja V. Nair, Aneesh Chandrasekharan, Tapas K. Manna · 2020 · Journal of Biological Chemistry
  55. FBXW7γ is a tumor-suppressive and prognosis-related FBXW7 transcript isoform in ovarian serous cystadenocarcinoma
    Zhou Xu, Lin Zhuang, Xiaoyin Wang, Qianrong Li, Sang Yan, Jiao Xu · 2020 · Future Oncology
  56. Proline-serine-threonine-repeat region of MDC1 mediates Chk1 phosphorylation and the DNA double-strand break repair
    Seung Ho Choi, Kyoungjoo Cho, Eun Seon Kim, Hae Yong Yoo · 2021 · The International Journal of Biochemistry & Cell Biology
  57. E3-ubiquitin ligase, FBXW7 regulates mitotic progression by targeting BubR1 for ubiquitin-mediated degradation
    Vishnu M. Nair, Amit Santhu Sabu, Ahmed Hussain, Delvin P. Kombarakkaran, R Bhagya Lakshmi, Tapas K. Manna · 2023 · Cellular and Molecular Life Sciences
  58. E3 Ubiquitin Ligases in Cancer and Their Pharmacological Targeting
    Joseph Y. Ong, Jorge Z. Torres · 2019 · IntechOpen eBooks
  59. Insertional mutagenesis using the Sleeping Beauty transposon system identifies drivers of erythroleukemia in mice
    Keith R. Loeb, Bridget Todd Hughes, Brian M. Fissel, Nyka J. Osteen, Sue E. Knoblaugh, Jonathan E. Grim, Luke J. Drury, Aaron L. Sarver, Adam J. Dupuy, Bruce E. Clurman · 2019 · Scientific Reports
  60. Loss of the Fbw7 tumor suppressor rewires cholesterol metabolism in cancer cells leading to activation of the PI3K-AKT signalling axis
    Maria T. Bengoechea-Alonso, Arwa Aldaalis, Johan Ericsson · 2022 · Frontiers in Oncology
  61. FBXW 7 inactivation in a BrafV600E‐driven mouse model leads to melanoma development
    Iraz T. Aydin, Franco Abbate, Geena Susan Rajan, Brateil Badal, Iannis Aifantis, Garrett T. Desman, Julide Tok Celebi · 2017 · Pigment Cell & Melanoma Research
  62. Mixed large cell neuroendocrine carcinoma and squamous cell carcinoma of the colon: detailed molecular characterisation of two cases indicates a distinct colorectal cancer entity
    Christine Woischke, Peter Jung, Andreas Jung, Jörg Kumbrink, Sibylle Eisenlohr, Christoph Josef Auernhammer, Michael W. Vieth, Thomas Kirchner, Jens H. L. Neumann · 2020 · The Journal of Pathology Clinical Research
  63. FBXO9 mediated the ubiquitination and degradation of YAP in a GSK-3β-dependent manner
    Yili Jin, Yun Xue, Jiatao Yao, Chengyun Xu, Rui Yu · 2025 · Journal of Biological Chemistry
  64. Epigenetic Regulation of IL-23 by E3 Ligase FBXW7 in Dendritic Cells Is Critical for Psoriasis-like Inflammation
    Yinjing Song, Xiangtong Zhao, Hao Qu, Yixin Su, Rukun He, Luxia Chen, Lutong Fang, Jiaying Li, Ziqi Zou, Jia He et al. · 2023 · The Journal of Immunology
  65. The FBXW7‐RPAP2 Axis Controls the Growth of Hepatocellular Carcinoma Cells and Determines the Fate of Liver Cell Differentiation
    Danrui Cui, Shengpeng Shao, Ruirui Qu, Xiaoyu Chen, Shanghong Jiang, Linchen Wang, Longyuan Gong, Tianqi Li, Danyi Zhai, Wenfeng Song et al. · 2025 · Advanced Science
  66. The tumor suppressor archipelago E3 ligase is required for spermatid differentiation in Drosophila testis
    Viktor Vedelek, Attila Kovács, Gábor Juhász, Elham I. Alzyoud, Rita Sinka · 2021 · Scientific Reports
  67. Tumor‐suppressor Fbxw7 targets SIK2 for degradation to interfere with TORC2‐AKT signaling in pancreatic cancer
    M Zhang, Hao Wang, Guo‐ping Sun · 2020 · Cell Biology International
  68. Approaches to functionally validate candidate genetic variants involved in colorectal cancer predisposition
    Laia Bonjoch, Pilar Mur, Coral Arnau‐Collell, Gardenia Vargas‐Parra, Bahar Shamloo, Sebastià Franch‐Expósito, Marta Pineda, Gabriel Capellá, Batu Erman, Sergi Castellvı́-Bel · 2019 · Molecular Aspects of Medicine
  69. Comprehensive Study of Human FBXW7 Deleterious nsSNP’s Functional Inference and Susceptibility to Gynaecological Cancer
    K. Archana Vasuki, Jemmy Christy · 2021 · Applied Biochemistry and Biotechnology
  70. FBXW7 is a biologically validated cancer driver gene for CLL
    Davide Rossi · 2019 · Blood
  71. Ubiquitin signaling in the control of centriole duplication
    Binshad Badarudeen, Ushma Anand, Swarnendu Mukhopadhyay, Tapas K. Manna · 2021 · FEBS Journal
  72. FBXW7β isoform drives transcriptional activation of the proinflammatory TNF cluster in human pro-B cells
    Scarlett Y. Yang, Katharina E. Hayer, Hossein Fazelinia, Lynn A. Spruce, Mukta Asnani, Kathryn L. Black, Ammar S. Naqvi, Vinodh Pillai, Yoseph Barash, Kojo S.J. Elenitoba‐Johnson et al. · 2022 · Blood Advances
  73. Deregulated ERK1/2 MAP kinase signaling promotes aneuploidy by a Fbxw7β-Aurora A pathway
    Stéphanie Duhamel, Charlotte Girondel, Jonas F. Dorn, Pierre‐Luc Tanguay, Laure Voisin, Ron Smits, Paul S. Maddox, Sylvain Meloche · 2016 · Cell Cycle
  74. PIP degron-stabilized Dacapo/p21Cip1 and mutations inagoact in an anti- versus pro-proliferative manner, yet both trigger an increase in Cyclin E levels
    Caroline Bivik Stadler, Badrul Arefin, Helen Ekman, Stefan Thor · 2019 · Development
  75. Knockout Mouse Models Provide Insight into the Biological Functions of CRL1 Components
    Tadashi Nakagawa, Keiko Nakayama, Keiko Nakayama · 2020 · Advances in experimental medicine and biology
  76. Somatic gain-of-function mutations in BUD13 promote oncogenesis by disrupting Fbw7 function
    Jianfeng Chen, Xinyi Zhang, Xianming M. Tan, Pengda Liu · 2023 · The Journal of Experimental Medicine
  77. Functional analysis reveals driver cooperativity and novel mechanisms in endometrial carcinogenesis
    Matthew Brown, Alicia Leon, Katarzyna Kedzierska, C. Moore, Hayley L. Belnoue-Davis, Susanne Flach, John P. Lydon, Francesco John DeMayo, Annabelle Lewis, Tjalling Bosse et al. · 2023 · EMBO Molecular Medicine
  78. FBXW7 in gastrointestinal cancers: from molecular mechanisms to therapeutic prospects
    Wanqing Wang, Xue Liu, Lingling Zhao, Kaipeng Jiang, Ziyi Yu, Ruihan Yang, Wenshuo Zhou, Jiuwei Cui, Tingting Liang · 2024 · Frontiers in Pharmacology
  79. Expression levels of FBXW7 and MDM2 E3 ubiquitin ligases and their c‑Myc and p53 substrates in patients with dysplastic nevi or melanoma
    Julija Mozūraitienė, Živilė Gudlevičienė, Ieva Vincerževskienė, Aida Laurinavičienė, Justinas Pamedys · 2020 · Oncology Letters
  80. Effect of citalopram and buspirone on the antinociceptive action of analgesic drugs.
    Wanda Pakulska, Elzbieta Czarnecka · 2001 · PubMed
  81. Involvement of F-box proteins in esophageal cancer (Review)
    Jian Gong, Zheng Huang, Jirong Huo · 2016 · International Journal of Oncology
  82. SOX9-dependent fibrosis drives renal function in nephronophthisis
    Maulin Mukeshchandra Patel, Vasileios Gerakopoulos, Bryan Lettenmaier, Eleni Petsouki, Kurt A. Zimmerman, John Andrew Sayer, Leonidas Tsiokas · 2025 · EMBO Molecular Medicine
  83. Harnessing the FBXW7 Somatic Mutant R465C for Targeted Protein Degradation
    Ananya A. Basu, Chenlu Zhang, Milad Rouhimoghadam, Anil Vasudevan, Justin M. Reitsma, Xiaoyu Zhang · 2025 · Journal of the American Chemical Society
  84. Pathology and Molecular Pathology of Colorectal Cancer
    Emily J. Poulin, Jeanne Shen, Jessica J. Gierut, Kevin M. Haigis · 2016 · Springer eBooks
  85. The stability of Fbw7α in M-phase requires its phosphorylation by PKC
    Sihem Zitouni, Francisca Méchali, Catherine Papin, Armelle Choquet, Daniel Barry Roche, Véronique Baldin, Olivier Coux, Catherine Bonne-Andréa · 2017 · PLoS ONE
  86. Proinflammatory Signaling Pathways and Genomic Signatures in Head and Neck Cancers
    Zhong Chen, Ramya Viswanathan, Ethan L. Morgan, Jun Jeon, Carter Van Waes · 2021 · Springer eBooks
  87. CAUSES OF CANCER
    Michaela Ruth Reagan · 2019 · Cancer
  88. A Perspective on Therapeutic Targeting Against Ubiquitin Ligases to Stabilize Tumor Suppressor Proteins
    Ishaar P. Ganesan, Hiroaki Kiyokawa · 2025 · Cancers
  89. Maritoclax Overcomes FBW7 Deficiency‐Driven Irinotecan Resistance in Colorectal Cancer by Targeting MCL1
    Qian Lin, Shuting Liu, Hongfei Jiang, Shasha Wang, Yixin Duan · 2025 · Cancer Medicine
  90. Tumor-derived branched-chain α-keto acids activate Notch signaling in tumor-associated macrophages to limit immunity
    Qixiang Ma, Ru Zhao, Jiangxue Han, Wen-Ying Zhu, Mi‐die Xu, Xiao-Yan Zhang, Guoquan Yan, Wenyu Wen, Guang-Chun Han, Min Luo et al. · 2026 · Nature Immunology
  91. Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study
    Luana Calabrò, Francesca Pia Caruso, Alessia Covre, Teresa Noviello, Maria Fortunata Lofiego, Rossella Tufano, Luigi Ferraro, Piera Grisolia, Antonio De Falco, Vincenzo Lagano et al. · 2026 · Nature Genetics
  92. Calpain-mediated cleavage of Fbxw7 during excitotoxicity
    Yeon Uk Ko, Hwa Young Song, Won-Ki Kim, Tae Young Yune, Nuri Yun, Young J. Oh · 2020 · Neuroscience Letters
  93. Prognostic and Predictive Implications of Cytogenetics and Genomics
    Viktor Ljungström, Panagiotis Baliakas · 2021 · Hematology/Oncology Clinics of North America
  94. Discovering Uncharted Binding Pockets on E3 Ligases Leads to the Identification of FBW7 Allosteric Modulators
    Miriam Martínez‐Cartró, Álvaro Serrano‐Morrás, Andrea Bertran‐Mostazo, Roger Castaño‐Muñiz, Salvatore Scaffidi, Varbina Ivanova, Noémi Csorba, József Simon, Péter Ábrányi‐Balogh, Yunfeng Li et al. · 2025 · Advanced Science
  95. Isoform alterations in the ubiquitination machinery impacting gastrointestinal malignancies
    Srimathi Kasturirangan, Derek J. Nancarrow, Ayush Shah, Kiran H. Lagisetty, Theodore Steven Lawrence, David G. Beer, Dipankar Ray · 2024 · Cell Death and Disease
  96. A (heat) shocking development: FBXW 7 loss unleashes HSF 1 to drive melanoma invasion and metastasis
    Eunpi Cho, Jonathan E. Grim · 2015 · Pigment Cell & Melanoma Research
  97. F‑box/WD‑40 repeat‑containing protein 7: A potential target in the progression and treatment of gastrointestinal malignancy (Review)
    Yizhi Wang, Yang An, Yi Ma, Junchao Guo · 2019 · Oncology Letters
  98. A peripheral T-cell lymphoma (PTCL) arising as a post-transplant lymphoproliferative disorder: efficacy of pralatrexate in primary refractory disease and review of the literature
    Helen Ma, Govind Bhagat, Owen A. O’Connor · 2019 · Leukemia & lymphoma/Leukemia and lymphoma
  99. Prolonged survival following everolimus combined with temozolomide for metastatic malignant melanoma with FBXW7 mutation: a case report and literature review
    Bin Wang, Chao Qu, Qin Zhao, Huanhuan Wang, Jinlong Wei, Lingbin Meng, Ying Xin, Lihua Dong, Xin Mei Jiang · 2021 · Annals of Palliative Medicine
  100. CDK1 and CDK2 regulate phosphorylation-dependent NICD1 turnover and the periodicity of the segmentation clock
    Francesca A. Carrieri, Philip J. Murray, Paul Davies, Jacqueline Kim Dale · 2018 · bioRxiv (Cold Spring Harbor Laboratory)